S. Goldstein

发表

Increased bone marrow CD56bright natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

Rushang D. Patel, Ren-Ching Wang, S. Mori, 2018, Bone Marrow Transplantation.

Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.

H. Lazarus, S. Devine, R. Maziarz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies

D. Porter, S. Goldstein, 2010, Expert review of hematology.

B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality

S. Paczesny, D. Couriel, A. Alousi, 2017, Bone Marrow Transplantation.

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation

D. Porter, S. Emerson, A. Perl, 2005, Bone Marrow Transplantation.

Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance

J. McQuade, D. Porter, S. Schuster, 2012, Bone Marrow Transplantation.

Post‐transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high‐dose melphalan with autologous stem cell support

D. Porter, E. Glatstein, S. Schuster, 2007, American journal of hematology.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

J. Vose, J. Winter, P. Hari, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase 1/2 trial of vorinostat plus tacrolimus and mycophenolate to prevent graft versus host disease following related donor reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

J. Dipersio, C. Dinarello, Thomas Braun, 2014 .

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

T. Braun, R. Soiffer, C. Dinarello, 2018, Blood.

Prophylaxis of Acute GVHD Using Multistem® Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses in a Phase 1 Trial

H. Lazarus, R. Maziarz, Robert Perry, 2012 .

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

H. Lazarus, R. Maziarz, Robert Perry, 2011 .

Stromal Stem Cell Therapy for Prophylaxis of Acute GVHD: Preliminary Results From a Phase 1 Trial

H. Lazarus, S. Devine, R. Maziarz, 2011 .

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

T. Braun, S. Choi, D. Couriel, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor‐derived constitutional abnormality

P. Nowell, D. Porter, S. Luger, 2008, American journal of hematology.

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency

J. Perkins, D. Sullivan, K. Fields, 1997, Bone Marrow Transplantation.

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

P. Gimotty, D. Porter, R. Elstrom, 2005, Bone Marrow Transplantation.

APhase I Study of Bexarotene, a Retinoic X ReceptorAgonist, in Non-M3 AcuteMyeloid Leukemia

A. Bagg, D. Porter, S. Schuster, 2008 .

Study of Bexarotene , a Retinoic X ReceptorAgonist , in Non-M 3 AcuteMyeloid Leukemia

A. Bagg, D. Porter, S. Schuster, 2008 .

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

D. Porter, F. Locatelli, E. Holler, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens

D. Porter, A. Perl, S. Luger, 2013, American journal of hematology.

Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?

Annette S. Kim, A. Bagg, V. V. Van Deerlin, 2008, American journal of clinical pathology.

Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene

P. Nowell, M. Carroll, A. Bagg, 2007, Cancer biology & therapy.

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas

D. Porter, Ellen J. Kim, A. Rook, 2011, Bone Marrow Transplantation.

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

T. Braun, D. Hanauer, S. Choi, 2015, Bone Marrow Transplantation.

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

J. Perkins, J. Greene, R. Sandin, 2006, Bone Marrow Transplantation.

Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease

D. Porter, A. Perl, S. Luger, 2010, Bone Marrow Transplantation.

Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature

Rushang D. Patel, S. Messina, S. Mori, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Aggressive Leukemic Non‐Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy

Sarfraz Ahmad, D. Persky, Rushang D. Patel, 2019, Clinical lymphoma, myeloma & leukemia.

Treatment of Acute Graft-vs-Host Disease

D. Porter, S. Goldstein, S. Stein, 2010 .

Structural and biosvnthetic features of the Mo 5 human myelGd differentiation antigen

S. Goldstein, F. R., 2007 .

Structural and biosynthetic features of the Mo5 human myeloid differentiation antigen.

R. Todd, S. Goldstein, 1993, Tissue antigens.

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.

T. Braun, S. Choi, D. Couriel, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma

L. Moscinski, L. Kronish, K. Fields, 1997, British journal of haematology.

Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.

J. Perkins, K. Fields, G. Elfenbein, 1997, The American journal of the medical sciences.

Concepts and Controversies in the Use of Novel Preparative Regimens for Allogeneic Stem Cell Transplantation

S. Luger, S. Goldstein, 2010 .

Cryopreservation of Allogeneic Stem Cell Products

N. Frey, S. Goldstein, 2010 .

Has allogeneic stem cell cryopreservation been given the ‘cold shoulder’? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation

H. Lazarus, N. Frey, S. Goldstein, 2006, Bone Marrow Transplantation.

Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.

Katherine G. Evans, Ellen J. Kim, A. Rook, 2009, Archives of dermatology.

Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections.

Sarfraz Ahmad, Rushang D. Patel, S. Mori, 2021, Transplantation and cellular therapy.

Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study

D. Hanauer, D. Couriel, G. Yanik, 2013 .

Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.

Sarfraz Ahmad, Rushang D. Patel, S. Mori, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Etanercept plus topical corticosteroids as initial therapy for grade 1 acute graft-versus-host disease after allogeneic hematopoietic cell transplant

T. Braun, S. Choi, S. Paczesny, 2014 .

The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.

M. Horowitz, J. Wingard, B. Shaw, 2021, Transplantation and cellular therapy.

J. Vose, P. Hari, R. Gale, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

J. Vose, P. Hari, R. Gale, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303.

P. Hari, M. Pasquini, R. Soiffer, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.

M. Pasquini, M. Horowitz, J. Wingard, 2009, Blood.

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.

T. Braun, S. Mineishi, S. Choi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ex-vivo via CD3/CD28 co-stimulation A phase I trial of donor lymphocyte infusions expanded and activated

D. Porter, B. Levine, S. Emerson, 2012 .

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

Alexander Perl, Bruce L Levine, David L Porter, 2006, Blood.

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD 3 / CD 28 costimulation

D. Porter, B. Levine, C. June, 2006 .

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

T. Braun, J. Dipersio, C. Dinarello, 2014, The Lancet. Oncology.

Eltrombopag Treatment for Primary and Secondary Thrombocytopenia Post Allogeneic and Autologous Stem Cell Transplantation is Effective and Safe

Rushang D. Patel, S. Mori, S. Goldstein, 2018 .

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT

D. Heitjan, D. Porter, S. Luger, 2012, Bone Marrow Transplantation.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

J. Wingard, D. Stroncek, B. Shaw, 2013, Blood.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Alan M. Miller, J. Armitage, J. Vose, 2003, Blood.

Phase II Trial of Vorinostat plus Tacrolimus & Mycophenolate to prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant Blood and Marrow Transplantation Program University of Michigan Comprehensive Cancer Center

T. Braun, S. Choi, D. Couriel, 2012 .

Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial

S. Choi, D. Couriel, G. Yanik, 2016 .

Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.

J. Hoxie, D. Heitjan, D. Porter, 2012, The New England journal of medicine.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

J. Vose, J. Fay, S. Bhatia, 2003, Blood.

Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission

T. Braun, S. Mineishi, S. Choi, 2015, Annals of Hematology.

Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia

P. Fu, M. de Lima, P. Caimi, 2020, Leukemia & lymphoma.

Marrow Transplant Clinical Trials Network phasecorticosteroids for acute graft-versus-host disease : a randomized Etanercept , mycophenolate , denileukin , or pentostatin plus

M. Pasquini, M. Horowitz, J. Wingard, 2009 .

Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study

J. Hoxie, D. Heitjan, D. Porter, 2011 .

D. Porter, S. Luger, E. Hexner, 2016, American journal of hematology.

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

P. Westervelt, M. Pasquini, M. Horowitz, 2014, Blood.

Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.

D. Porter, B. Levine, C. June, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia

M. Carroll, A. Bagg, D. Porter, 2008, Clinical Cancer Research.

A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia

M. Carroll, A. Bagg, D. Porter, 2009, Clinical Cancer Research.

Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic cell transplantation

G. Yanik, J. Magenau, E. Gatza, 2016, Bone Marrow Transplantation.

Influence Of Race and Ethnicity On The Collection Of G-CSF Mobilized Peripheral Blood Stem Cells From Unrelated Donors, a Center For International Blood and Marrow Transplant Research Analysis

J. Wingard, B. Shaw, B. Logan, 2013 .

BMT CTN 0302: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox, and Pentostatin in Combination with Corticosteroids in 180 Patients (pts) with Newly Diagnosed Acute Graft Vs. Host Disease (aGVHD)

M. Horowitz, J. Wingard, D. Weisdorf, 2008 .

Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates

J. Perkins, D. Sullivan, Jongphil Kim, 2011, Clinical Cancer Research.

Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.

T. Braun, D. Couriel, G. Yanik, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD‐SelMQC‐CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia

T. Floyd, R. Reddy, S. Kim, 2009, Magnetic resonance in medicine.

Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.

J. Perkins, K. Fields, G. Elfenbein, 1996, Bone Marrow Transplantation.

A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients

Jennifer L Davis, N. Mitra, T. Miano, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

J. Armitage, J. Vose, E. Montserrat, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

M. Pasquini, M. Horowitz, J. Wingard, 2009, Blood.

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

T. Braun, S. Choi, D. Couriel, 2017, Biology of Blood and Marrow Transplantation.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

T. Braun, R. Soiffer, C. Dinarello, 2018, Blood.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

J. Wingard, D. Stroncek, B. Shaw, 2013, Blood.

Impact of Dose Intensification of FluBu2 to FluBu4 on Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission

T. Braun, S. Mineishi, S. Choi, 2013 .

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

S. Schuster, J. Svoboda, T. Ahmadi, 2009 .

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

T. Braun, S. Choi, S. Paczesny, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase I Dose Escalation Study of the mTOR Inhibitor Sirolimus and MEC Chemotherapy Targeting Signal Transduction in Leukemic Stem Cells for Acute Myeloid Leukemia.

M. Carroll, D. Porter, S. Emerson, 2006 .